NYSE · BRK-B
Berkshire Hathaway Inc.
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
Loading market information…
NASDAQ · MITA · USD
Stock price, earnings
Quote as of Dec 26, 2024, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Coliseum Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Coliseum Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Coliseum Acquisition Corp. currently possesses no substantive business activities. The company's primary objective involves completing a business combination such as a merger, stock exchange, asset acquisition, share purchase, or corporate reorganization with one or more other entities. Established in 2021, the firm maintains its principal office in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$11.86-$0.07 (-0.59%)
Integrated Wellness Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 8.77% below the high.
$8.88-$1.04 (-10.48%)
Focus Impact Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 40.8% below the high.
$10.34+$0.00 (+0.01%)
Jupiter Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 6.59% below the high.
$9.50-$1.87 (-16.45%)
Insight Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 29.58% below the high.
$9.24-$2.06 (-18.23%)
ExcelFin Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.66% below the high.
$11.66+$0.46 (+4.11%)
Nocturne Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 16.6% below the high.
$10.00-$0.36 (-3.47%)
Roth CH Acquisition IV Co.’s quoted price sits in the lower half of its reported 52-week range, 33.29% below the high.
